TCRT icon

Alaunos Therapeutics

154 hedge funds and large institutions have $270M invested in Alaunos Therapeutics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 46 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 46

20% less capital invested

Capital invested by funds: $336M → $270M (-$66.8M)

Holders
154
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.98M
Puts
$2.32M
Net Calls
Net Calls Change

Top Buyers

1 +$3.47M
2 +$1.93M
3 +$1.91M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.89M
5
Bank of America
Bank of America
North Carolina
+$1.52M

Top Sellers

1 -$899K
2 -$590K
3 -$507K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$396K
5
UBS Group
UBS Group
Switzerland
-$273K
Name Holding Trade Value Shares
Change
Change in
Stake
101
$54K
102
$50K
103
$47K
104
$46K
105
$44K
106
$43K
107
$41K
108
$40K
109
$40K
110
$38K
111
$38K
112
$38K
113
$38K
114
$33K
115
$31K
116
$31K
117
$30.1K
118
$30K
119
$30K
120
$30K
121
$29K
122
$28K
123
$28K
124
$27K
125
$27K